The European Patent Office (EPO) has officially granted patent EP3121280B1, titled 'Antisense compositions and methods of making and using same.' This patent, designated with kind code B1, was granted on March 18, 2026, and lists Sergio Baroni, Salvatore Bellinvia, and Francesca Viti as inventors. The patent's International Patent Classification (IPC) includes C12N 15/113 and A61K 31/7088, indicating its focus on biotechnology and pharmaceutical compositions.

This grant represents a new intellectual property right for the patent holders within the designated European states. While this is a notice of a granted patent and not a regulatory rule imposing new obligations, companies operating in the biotechnology and pharmaceutical sectors, particularly those involved with antisense technology, should be aware of this granted patent. Compliance officers should ensure their product development and research activities do not infringe upon this patent, and legal teams may need to assess freedom-to-operate in relevant markets.